Reinventing Aptamer Science: The Neomer Platform In 2022, NeoVentures Biotechnology revolutionized aptamer science by introducing reproducibility, paving the way for the next generation of aptamers. Using our neomer platform, we reduced the number of random nucleotides while preserving optimal structural diversity. This innovation addressed the… Leer más »The Next Generation of Aptamers
Una historia incluida en Las Mil y Una Noches es la historia de Aladino. Un niño pobre que un día logra engañar al malvado hechicero y obtener la lámpara mágica. Dentro de la lámpara vive el genio, quien le concederá todos sus deseos. Ahora,... Leer más »Por qué los anticuerpos desearían ser ADN
En el dinámico ámbito de la biología molecular, la búsqueda de mejorar herramientas diagnósticas y enfoques terapéuticos es un viaje en constante evolución. Un avance significativo en esta búsqueda es el desarrollo de la biblioteca Neomer, una plataforma innovadora que permite la utilización de secuencias idénticas en diversas... Leer más »A Revolutionary Approach to Aptamer Characterization
El método de selección de aptámeros Neomer de NeoVentures reemplaza el proceso tradicional SELEX, ofreciendo un espacio cerrado y reproducible para el desarrollo de aptámeros, asegurando consistencia en la detección de niveles de medicamentos. La inclusión de un paso de tolerancia inmune in-silico mejora la especificidad y selectividad de los aptámeros Neomer, haciéndolos más precisos en la detección... Leer más »Revolutionizing Drug Level Detection: Neomer Aptamers
In recent years, the field of therapeutics has witnessed remarkable advancements in the development of novel treatment strategies. Among the emerging approaches, aptamers have emerged as powerful tools with immense potential in various therapeutic applications. Aptamers, short single-stranded nucleic acid or peptide molecules, can specifically… Leer más »Unlocking Therapeutic Potential: Aptamers as Tools in Medicine
NeoVentures was formed as an aptamer development company in June of 2002, and founded on a very simple principle. Businesses that create real sustainable value for their clients succeed. This does not always seem to be case as we have all seen biotechnology companies that… Leer más »Why has NeoVentures succeeded as an Aptamer development company?
Aptamers are selected from large libraries of random sequences, thus aptamers themselves are not designed but the libraries that they are selected from are. The standard method of aptamer design has been for SELEX selection. This involves a synthetic library with a random region flanked… Leer más »Aptamer Libraries – What is Neomers?
Antibody Binding vs. Aptamer Binding The immune system has developed very effective screening methods for eliminating antibodies that bind even weakly to self targets such as serum albumin and IgG. Aptamer selection is done outside the body, on the bench which provides many advantages but implicit… Leer más »How We Avoid Self-Recognition with Aptamers
The use of the traditional SELEX method for aptamer development has led to the identification of aptamers that bind to a wide diversity of targets. However, there has been limited success with aptamers in therapeutic and diagnostic applications. A key advantage of aptamer development over… Leer más »Announcing The Future of Aptamers: Neomers
This is the first of several blogs we will share on our new Neomer process. The image above can be compared to a dilemma in traditional aptamer selection: are the aptamers that are enriching the product of the selection process (I would vote for the… Leer más »How We Overcome Process Bias with Neomers
Spanish 
English 
French